Chunze Li

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Early Breast Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Clinical and translational science

Cancer chemotherapy and pharmacology

CPT: pharmacometrics & systems pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Brendan Bender, Chi-Chung Li, Mathilde Marchand, David C Turner, Feifei Li, Shweta Vadhavkar, Bei Wang, Rong Deng, James Lu, Jin Yan Jin, Chunze Li, Shen Yin, Michael Wei, Pascal Chanu
Population pharmacokinetics and CD20 binding dynamics for mosunetuzumab in relapsed/refractory B-cell non-Hodgkin lymphoma. Clinical and translational science 17 (6) (2024)
Brendan Bender, Chi-Chung Li, Mathilde Marchand, David C Turner, Feifei Li, Shweta Vadhavkar, Bei Wang, Rong Deng, James Lu, Jin Yan Jin, Chunze Li, Shen Yin, Michael Wei, Pascal Chanu
Population pharmacokinetics and CD20 binding dynamics for mosunetuzumab in relapsed/refractory B-cell non-Hodgkin lymphoma. Clinical and translational science 17 (6) (2024)
Brendan Bender, Chi-Chung Li, Mathilde Marchand, David C Turner, Feifei Li, Shweta Vadhavkar, Bei Wang, Rong Deng, James Lu, Jin Yan Jin, Chunze Li, Shen Yin, Michael Wei, Pascal Chanu
Population pharmacokinetics and CD20 binding dynamics for mosunetuzumab in relapsed/refractory B-cell non-Hodgkin lymphoma. Clinical and translational science 17 (6) (2024)
Brendan Bender, Chi-Chung Li, Mathilde Marchand, David C Turner, Feifei Li, Shweta Vadhavkar, Bei Wang, Rong Deng, James Lu, Jin Yan Jin, Chunze Li, Shen Yin, Michael Wei, Pascal Chanu
Population pharmacokinetics and CD20 binding dynamics for mosunetuzumab in relapsed/refractory B-cell non-Hodgkin lymphoma. Clinical and translational science 17 (6) (2024)
Yuan Chen, Fang Ma, Nicholas Jones, Rong Deng, Chunze Li, Chi-Chung Li
Assessment of CYP3A-mediated drug interaction via cytokine (IL-6) elevation for mosunetuzumab using physiologically-based pharmacokinetic modeling. CPT: pharmacometrics & systems pharmacology (2023)
René Bruno, Mathilde Marchand, Kenta Yoshida, Phyllis Chan, Haocheng Li, Wei Zou, Francois Mercier, Pascal Chanu, Benjamin Wu, Anthony Lee, Chunze Li, Jin Yan Jin, Michael L Maitland, Martin Reck, Mark A Socinski
Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
René Bruno, Mathilde Marchand, Kenta Yoshida, Phyllis Chan, Haocheng Li, Wei Zou, Francois Mercier, Pascal Chanu, Benjamin Wu, Anthony Lee, Chunze Li, Jin Yan Jin, Michael L Maitland, Martin Reck, Mark A Socinski
Tumor dynamic model-based decision support for Phase Ib/II combination studies: A retrospective assessment based on resampling of the Phase III study IMpower150. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
René Bruno, Mathilde Marchand, Kenta Yoshida, Phyllis Chan, Haocheng Li, Wei Zou, Francois Mercier, Pascal Chanu, Benjamin Wu, Anthony Lee, Chunze Li, Jin Yan Jin, Michael L Maitland, Martin Reck, Mark A Socinski
Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
René Bruno, Mathilde Marchand, Kenta Yoshida, Phyllis Chan, Haocheng Li, Wei Zou, Francois Mercier, Pascal Chanu, Benjamin Wu, Anthony Lee, Chunze Li, Jin Yan Jin, Michael L Maitland, Martin Reck, Mark A Socinski
Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
René Bruno, Mathilde Marchand, Kenta Yoshida, Phyllis Chan, Haocheng Li, Wei Zou, Francois Mercier, Pascal Chanu, Benjamin Wu, Anthony Lee, Chunze Li, Jin Yan Jin, Michael L Maitland, Martin Reck, Mark A Socinski
Tumor dynamic model-based decision support for Phase Ib/II combination studies: A retrospective assessment based on resampling of the Phase III study IMpower150. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Bei Wang, Rong Deng, Stefanie Hennig, Tanja Badovinac Crnjevic, Monika Kaewphluk, Matts Kågedal, Angelica L Quartino, Sandhya Girish, Chunze Li, Whitney P Kirschbrown
Correction to: Population pharmacokinetic and exploratory exposure-response analysis of the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer in the FeDeriCa study. Cancer chemotherapy and pharmacology (2021)
Stephanie N Liu, Chunze Li
Clinical pharmacology strategies in supporting drug development and approval of antibody-drug conjugates in oncology. Cancer chemotherapy and pharmacology 87 (6) (2021)
Bei Wang, Rong Deng, Stefanie Hennig, Tanja Badovinac Crnjevic, Monika Kaewphluk, Matts Kågedal, Angelica L Quartino, Sandhya Girish, Chunze Li, Whitney P Kirschbrown
Population pharmacokinetic and exploratory exposure-response analysis of the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer in the FeDeriCa study. Cancer chemotherapy and pharmacology 88 (3) (2021)